Abstract:Serial measurements of the levels of thyroxine (T4), triiodothyronine (T3) and thyrotrophin (TSH) have been made in sixty‐two patients with thyrotoxicosis during the management of their disease. Thirty‐six patients received 131I, twenty antithyroid drugs and six underwent thyroidectomy. All have been followed for 1–2 years. Serum T4 concentrations were determined by a modification of the Murphy technique (N: 5–12 μg/100 ml). Serum T3 values were assessed by the method of Sterling et al. (N: 150–270 ng/100 ml). TSH was measured by radioimmunoassay (N: 0–8 μU/ml). The following hormonal and clinical patterns were observed. 1 Euthyroidism, with normal T4, T3 and TSH in forty‐four patients. 2 Persistence of hyperthyroidism with high serum T3 (370–676 ng/100 ml), normal T4 and undetectable TSH, in four patients treated with 131I and in four managed with antithyroid drugs. 3 In four out of six patients, clinically euthyroid after 131I therapy, serum TSH became elevated (32–93 μU/ml). In this group serum T4 was decreased (1.3–3.6 μg/100 ml), but T3 was normal or somewhat elevated (170–348 ng/100 ml). Three of these patients eventually developed hypothyroidism and T3 levels fell below normal. 4 Four patients showed a transient (2–4 months) fall of serum T4 below the normal level. Serum T3 was normal and they were clinically euthyroid. Euthyroidism, with normal T4, T3 and TSH in forty‐four patients. Persistence of hyperthyroidism with high serum T3 (370–676 ng/100 ml), normal T4 and undetectable TSH, in four patients treated with 131I and in four managed with antithyroid drugs. In four out of six patients, clinically euthyroid after 131I therapy, serum TSH became elevated (32–93 μU/ml). In this group serum T4 was decreased (1.3–3.6 μg/100 ml), but T3 was normal or somewhat elevated (170–348 ng/100 ml). Three of these patients eventually developed hypothyroidism and T3 levels fell below normal. Four patients showed a transient (2–4 months) fall of serum T4 below the normal level. Serum T3 was normal and they were clinically euthyroid. These results show that during the management of thyrotoxicosis, serum T4 may be misleading. The measurement of T3 and TSH, in addition to T4, provides a better correlation between clinical status and laboratory findings.

The serum triiodothyronine to thyroxine (T3/T4) ratio in various thyroid disorders and after Levothyroxine replacement therapy

Triiodothyronine/Thyroxine Ratio as a Marker of Clinical Response to Levothyroxine Replacement in Patients With Hypothyroidism

PATTERN OF SERUM THYROXINE, TRIIODOTHYRONINE AND THYROTROPHIN AFTER TREATMENT OF THYROTOXICOSIS

Differentiating Graves' disease from subacute thyroiditis using ratio of serum free triiodothyronine to free thyroxine

Triiodothyronine levels in athyreotic pediatric patients during levothyroxine therapy

Clinical Evaluation of Various Thyroid Hormones on Thyroid Function

The Effects of Triiodothyronine on the Free Thyroxine Set Point Position in the Hypothalamus Pituitary Thyroid Axis

Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease

Relational Stability of Thyroid Hormones in Euthyroid Subjects and Patients with Autoimmune Thyroid Disease

Integration of Peripheral and Glandular Regulation of Triiodothyronine Production by Thyrotropin in Untreated and Thyroxine-Treated Subjects

Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients

Syndromes related to defective iodothyronine metabolism

The value of FT4/TSH ratio in the differential diagnosis of Graves' disease and subacute thyroiditis

Diagnostic value of serum thyroxine and free thyroxine index.

Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves’ Disease From Autoimmune Thyroiditis

Role of serum thyroglobulin levels in differentiating hyperthyroidism and thyrotoxic phases of thyroiditis

Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients

Liothyronine and Desiccated Thyroid Extract in the Treatment of Hypothyroidism

Levothyroxine Therapy in Thyrodectomized Patients

A review of the safety of triiodothyronine in combination with levothyroxine for the management of hypothyroidism

TSH 30 mU/L may not be necessary for successful <SUP>131</SUP>I remnant ablation in patients with differentiated thyroid cancer